Session 3: Market Translation & Commercialization

Sponsored by

---

Vignette: Concepts Essential to Pre-Commercialization Success

Allyn Elliott                                           
Patent Attorney, NK Patent Law

Sonny Goyal                                          
SVP, Chief Strategy Officer
Head of Diversified Business Group at Blue Cross North Carolina

Russ King                                                
President, MethodSense, Inc.

Chris Morrison                                    
Owner, ViaVerus

---

Session 3: Market Translation & Commercialization

Session summary: The goal of this session is to provide an overview of high-level considerations and pathways for commercialization of medical devices and digital health/healthcare IT technologies. Progression towards commercialization is a multi-faceted and complex process, with aspects such as regulatory considerations, clinical data requirements, reimbursement, market entry strategies, technology adoption and integration all being components. Panelists will share their experience and advice on how newcomers can approach these areas.

Moderator:
Suresh Balu
Director, Duke Institute for Health Innovation (DIHI)
Assoc. Dean, Innovation and Partnership, Duke University School of Medicine 

Panelists:
Anne DeGheest
Managing Director, HealthTech Capital
Managing Director, MedStars

T. Bruce Ferguson, MD
CMO/Co-Founder, Perfusio Corp.
Chief Visiting Research Scientist for Departments of Engineering, Physics and Surgery, East Carolina University

Joseph Knight
President/CEO, InnAVasc Medical, Inc.
Adjunct Professor, Duke University

Kelly Reeves, BSN, RN, UXC
Research Nurse, Atrium Health